Skip to main content

AI FOR EARLY DETECTION OF SEPSIS

WHAT IS SEPSIS?

 Sepsis occurs when chemicals released in the bloodstream to fight an infection trigger inflammation throughout the body. This can cause a cascade of changes that damage multiple organ systems, leading them to fail, sometimes even resulting in death.

Symptoms include fever, difficulty breathing, low blood pressure, fast heart rate, and mental confusion.

Treatment includes antibiotics and intravenous fluids.

SYMPTOMS

Symptoms of sepsis may include:

  • Change in mental status.

  • Fast, shallow breathing.

  • Sweating for no clear reason.

  • Feeling lightheaded.

  • Shivering.

  • Symptoms specific to the type of infection, such as painful urination from a urinary tract infection or worsening cough from pneumonia.

Symptoms of sepsis are not specific. They can vary from person to person, and sepsis may appear differently in children than in adults.

CAUSES

Any type of infection can lead to sepsis. This includes bacterial, viral, or fungal infections. Those that more commonly cause sepsis include infections of:

  • Lungs, such as pneumonia.

  • Kidney, bladder and other parts of the urinary system.

  • Digestive system.

  • Bloodstream.

  • Catheter sites.

  • Wounds or burns.

TREATMENT

Early, thorough treatment raises the likelihood of recovery. People who have sepsis need close monitoring and treatment in a hospital intensive care unit. This is because people with sepsis may need lifesaving measures to stabilize breathing and heart action.

Medications

Different medications are used in treating sepsis and septic shock. They include:

  • Antibiotics. Treatment with antibiotics begins as soon as possible. Broad-spectrum antibiotics, which are effective against a variety of bacteria, are often used first. When blood tests results show which germ is causing the infection, the first antibiotic may get switched out for a second one. This second one targets the germ causing the infection.

  • Fluids added to veins. The use of intravenous fluids begins as soon as possible.

  • Vasopressors. Vasopressors narrow blood vessels and help increase blood pressure. A vasopressor medication may be used if blood pressure is too low even after receiving fluids.

AI AID IN THE DETECTION PROCESS

Artificial intelligence (AI) has surfaced as a new tool that can help rapidly detect sepsis in patients. Using AI algorithms, the tool detects several key sepsis risk factors in real time by monitoring patients' electronic medical records as physicians input information. Flagging high-risk patients can help facilitate early intervention, which can improve outcomes, lower healthcare costs, and save lives.

“It is the first instance where AI is implemented at the bedside, used by thousands of providers, and where we’re seeing lives saved,” said Suchi Saria, founding research director of the Malone Center for Engineering in Healthcare at Johns Hopkins and lead author of the study.

Since 2016, sepsis is defined as a “life-threatening organ dysfunction caused by a dysregulated host response to infection” . This definition replaces the previous definition from 1992 based on markers of systemic inflammation. The new definition of sepsis also replaces the old term “severe sepsis,” which was used to designate organ dysfunction caused by infection. The new definition provides a more accurate understanding of the pathophysiology of sepsis as well as more precise diagnostic criteria. Sepsis accompanied by circulatory failure is termed septic shock, the most severe form of sepsis. Together with the definition of sepsis, the recommendation for making a definitive diagnosis changed to “appropriate routine microbiologic cultures (including blood) be obtained before starting antimicrobial therapy in patients with suspected sepsis or septic shock if doing so results in no substantial delay in the start of antimicrobials”

Artificial intelligence (AI) has the potential to deliver timely and accurate sepsis detection, potentially outperforming current clinical warning scores, which are not based on sophisticated mathematical models. Early prediction of sepsis could be achieved by developing a decision support system based on machine learning (ML) algorithms trained on patient data, usually based on electronic medical records, biomedical signals, or laboratory results.

Comments

  1. This is good.keep up the good work. Waiting for your future work.

    ReplyDelete
  2. Chosen a very complex topic. It feels good to see young mind thinking towards making a better healthy society and working on its awareness. Congrats

    ReplyDelete

Post a Comment

Popular posts from this blog

Making sense of cell fate

  Despite the proliferation of novel therapies such as immunotherapy or targeted therapies, radiation and chemotherapy remain the frontline treatment for cancer patients. About half of all patients still receive radiation and 60-80 percent receive chemotherapy. Both radiation and chemotherapy work by damaging DNA, taking advantage of a vulnerability specific to cancer cells. Healthy cells are more likely to survive radiation and chemotherapy since their mechanisms for identifying and repairing DNA damage are intact. In cancer cells, these repair mechanisms are compromised by mutations. When cancer cells cannot adequately respond to the DNA damage caused by radiation and chemotherapy, ideally, they undergo apoptosis or die by other means. However, there is another fate for cells after DNA damage: senescence — a state where cells survive, but stop dividing. Senescent cells’ DNA has not been damaged enough to induce apoptosis but is too damaged to support cell division. While senescent ca

MAKING SENSE OF SANGER SEQUENCING

 WHAT IS SANGER SEQUENCING? Sanger sequencing is a method that yields information about the identity and order of the four nucleotide bases in a segment of DNA. Also known also as the “chain-termination method”, it was developed in 1977 by Frederick Sanger and colleagues, and is still considered the gold standard of sequencing technology today since it provides a high degree of accuracy, long-read capabilities, and the flexibility to support a diverse range of applications in many research areas In the mid-1970s, Sanger wasn’t alone in the race to sequence DNA; almost in parallel, two American scientists, Maxam and Gilbert, developed a technique in which DNA is chemically treated to break the chain at specific bases. Following electrophoresis of the cleaved DNA, the relative lengths of the fragments—and thus the positions of specific nucleotides—can be determined and the sequence inferred. This is considered the birth of first-generation sequencing. However, the advent of Sanger’s chai

GLOBAL COLLABORATION PROVIDES INSIGHT ON RARE NEUROENDOCRINE TUMORS

  Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas (PPGLs), which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread, according to Bruna Calsina, a researcher at the Spanish National Cancer Research Center (CNIO).  Surgical removal of the primary tumor is standard practice, with physicians relying on clinical characteristics of the tumor and patient symptoms in the absence of reliable molecular markers of metastatic potential, she says. The central problem is that PPGLs are exceedingly rare. Samples from more than 100 patients with metastatic disease were analyzed in the latest study, published in  Nature Communications , out of a pool